Lucia Seminario Vidal
Dermatology · Tampa, FLNPI 1588912869
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (48.9%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Kyowa Kirin, Inc. at 48.3% of the total. Reporting peaked in 2019 at $36,354 and has fallen 56.5% since, to $15,819 in 2021. Among dermatology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 54 payments — averaging $1026.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kyowa Kirin, Inc.$27K
- Helsinn Therapeutics (U.S.), Inc.$8K
- Boehringer Ingelheim$7K
- Novartis$6K
- Boehringer Ingelheim International GmbH$3K
- Regeneron Healthcare Solutions, Inc.$2K
- plus $3K from 6 others
Across 513 payments — averaging $3853.42 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eisai Inc.$848K
- Novartis$692K
- Eli Lilly$143K
- Boehringer Ingelheim$122K
- E.r. Squibb & Sons, L.L.C.$55K
- Glenmark Pharmaceuticals Inc., USA$33K
- plus $84K from 5 others
What the payments were for
- Consulting fees$27,09449%
- Speaking & faculty fees$24,00743%
- Travel & lodging$3,0876%
- Food & beverage$1,2002%
- Education$430%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kyowa Kirin, Inc. | 24 | $26,778 |
| Helsinn Therapeutics (U.S.), Inc. | 8 | $7,749 |
| Boehringer Ingelheim | 2 | $6,560 |
| Novartis | 8 | $5,975 |
| Boehringer Ingelheim International GmbH | 4 | $3,271 |
| Regeneron Healthcare Solutions, Inc. | 1 | $2,480 |
| Blueprint Medicines Corporation | 1 | $2,258 |
| Genentech USA, Inc. | 1 | $139 |
| AbbVie | 1 | $102 |
| Sun Pharmaceutical Industries Inc. | 1 | $60 |
| Mallinckrodt Enterprises LLC | 2 | $43 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$55,432 in reported general payments places this provider in the 90th percentile of 1,147 dermatology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 24 | $1,023 |
| Mupirocin | 11 | $56 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Tampa
- Seth FormanTampa$407K
- Asha ShahTampa$332K
- Nishit PatelTampa$111K
- Francisco KerdelMiami$2.1M
- Brad GlickMargate$2M
- Robert KirsnerMiami$1.4M
- John MinniStuart$1.4M
- Gil YosipovitchMiami$1M
- Shino Bay AguileraFt Lauderdale$1M
- Robert SnyderPembroke Pines$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.